Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern

Messenger RNA-based vaccines against COVID-19 induce a robust anti-SARS-CoV-2 antibody response with potent viral neutralization activity. Antibody effector functions are determined by their constant region subclasses and by their glycosylation patterns, but their role in vaccine efficacy is unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Farkash, Inbal, Feferman, Tali, Cohen-Saban, Noy, Avraham, Yahel, Morgenstern, David, Mayuni, Grace, Barth, Natasha, Lustig, Yaniv, Miller, Liron, Shouval, Dror S., Biber, Asaf, Kirgner, Ilya, Levin, Yishai, Dahan, Rony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610888/
https://www.ncbi.nlm.nih.gov/pubmed/34883043
http://dx.doi.org/10.1016/j.celrep.2021.110114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610888/
https://www.ncbi.nlm.nih.gov/pubmed/34883043
http://dx.doi.org/10.1016/j.celrep.2021.110114

Ejemplares similares